The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Targeting of TAK1 in inflammatory disorders and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Kinase inhibitors and airway inflammation
Adcock, I. M., Chung, K. F., Caramori, G., & Ito, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.054 · Cited by 141
RetractedSystematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182
TGFβ signalling: a complex web in cancer progression
Ikushima, H., & Miyazono, K. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2853 · Cited by 1,173
Essential function for the kinase TAK1 in innate and adaptive immune responses
Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1255 · Cited by 973
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Shim, J.-H., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K.-Y., Bussey, C., Steckel, M., Tanaka, N., et al. (2005) · Genes & Development · doi:10.1101/gad.1360605 · Cited by 738
Sun, L., Deng, L., Ea, C.-K., Xia, Z.-P., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00236-9 · Cited by 699
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., & Matsumoto, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80244-0 · Cited by 610
TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction
Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., & Matsumoto, K. (1996) · Science · doi:10.1126/science.272.5265.1179 · Cited by 587
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 575
Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains
Komander, D., Reyes‐Turcu, F., Licchesi, J. D. F., Odenwaelder, P., Wilkinson, K. D., & Barford, D. (2009) · EMBO reports · doi:10.1038/embor.2009.55 · Cited by 572
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.-H., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Ubiquitination in signaling to and activation of IKK
Chen, Z. J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01108.x · Cited by 417
Ninomiya-Tsuji, J., Kajino, T., Ono, K., Ohtomo, T., Matsumoto, M., Shiina, M., Mihara, M., Tsuchiya, M., & Matsumoto, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207453200 · Cited by 409
TAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells
Herrero‐Martín, G., Høyer‐Hansen, M., García‐García, C., Fumarola, C., Farkas, T., López‐Rivas, A., & Jäättelä, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.8 · Cited by 400
He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M., Xiong, H., Bussel, J. B., Chiu, A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1914 · Cited by 349
TAK1 Mediates the Ceramide Signaling to Stress-activated Protein Kinase/c-Jun N-terminal Kinase
Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K., & Nishida, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8141 · Cited by 335
Vidal, S., Khush, R. S., Leulier, F., Tzou, P., Nakamura, M., & Lemaitre, B. (2001) · Genes & Development · doi:10.1101/gad.203301 · Cited by 313
Hinz, M., Stilmann, M., Arslan, S. Ç., Khanna, K. K., Dittmar, G., & Scheidereit, C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.008 · Cited by 280
The TAK1–TRAF6 signalling pathway
Landström, M. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.023 · Cited by 280
Feedback control of the protein kinase TAK1 by SAPK2a/p38
Cheung, P. C. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg552 · Cited by 278
Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling
Ishitani, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg605 · Cited by 273
Wan, Y. Y., Chi, H., Xie, M., Schneider, M. D., & Flavell, R. A. (2006) · Nature Immunology · doi:10.1038/ni1355 · Cited by 262
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Singh, A., Sweeney, M. F., Yu, M., Burger, A., Greninger, P., Benes, C., Haber, D. A., & Settleman, J. (2012) · Cell · doi:10.1016/j.cell.2011.12.033 · Cited by 260
Nuclear initiated NF-κB signaling: nemo and ATM take center stage
Miyamoto, S. (2011) · Cell Research · doi:10.1038/cr.2010.179 · Cited by 253
Antigen Receptor Signaling to NF- B via CARMA1, BCL10, and MALT1
Thome, M., Charton, J. E., Pelzer, C., & Hailfinger, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003004 · Cited by 241
Oncogenic Ras Diverts a Host TNF Tumor Suppressor Activity into Tumor Promoter
Cordero, J. B., Macagno, J. P., Stefanatos, R. K., Strathdee, K. E., Cagan, R. L., & Vidal, M. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.014 · Cited by 239
Sakurai, H., Miyoshi, H., Toriumi, W., & Sugita, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10641 · Cited by 230
Self-citationTAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 207
Singhirunnusorn, P., Suzuki, S., Kawasaki, N., Saiki, I., & Sakurai, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407537200 · Cited by 206
Self-citationTwo-sided ubiquitin binding explains specificity of the TAB2 NZF domain
Kulathu, Y., Akutsu, M., Bremm, A., Hofmann, K., & Komander, D. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1731 · Cited by 200
Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation
Zhang, L., Ding, X., Cui, J., Xu, H., Chen, J., Gong, Y.-N., Hu, L., Zhou, Y., Ge, J., Lu, Q., et al. (2012) · Nature · doi:10.1038/nature10690 · Cited by 191
Helicobacter pylori CagA activates NF‐κB by targeting TAK1 for TRAF6‐mediated Lys 63 ubiquitination
Lamb, A., Yang, X., Tsang, Y. N., Li, J., Higashi, H., Hatakeyama, M., Peek, R. M., Blanke, S. R., & Chen, L. (2009) · EMBO reports · doi:10.1038/embor.2009.210 · Cited by 185
Fan, Y., Yu, Y., Shi, Y., Sun, W., Xie, M., Ge, N., Mao, R., Chang, A., Xu, G., Schneider, M. D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.076976 · Cited by 168
PKCβ regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1
Shinohara, H., Yasuda, T., Aiba, Y., Sanjo, H., Hamadate, M., Watarai, H., Sakurai, H., & Kurosaki, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051591 · Cited by 165
Self-citationThe E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation
Ahmed, N., Zeng, M., Sinha, I., Polin, L., Wei, W.-Z., Rathinam, C., Flavell, R., Massoumi, R., & Venuprasad, K. (2011) · Nature Immunology · doi:10.1038/ni.2157 · Cited by 160
TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils
Alagbala Ajibade, A., Wang, Q., Cui, J., Zou, J., Xia, X., Wang, M., Tong, Y., Hui, W., Liu, D., Su, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.010 · Cited by 159
O‐GlcNAcylation of TAB1 modulates TAK1‐mediated cytokine release
Pathak, S., Borodkin, V. S., Albarbarawi, O., Campbell, D. G., Ibrahim, A. F. M., & van Aalten, D. M. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.8 · Cited by 158
Essential role of TAK1 in thymocyte development and activation
Liu, H.-H., Xie, M., Schneider, M. D., & Chen, Z. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603089103 · Cited by 157
TAK1 Is a Master Regulator of Epidermal Homeostasis Involving Skin Inflammation and Apoptosis
Omori, E., Matsumoto, K., Sanjo, H., Sato, S., Akira, S., Smart, R. C., & Ninomiya‐Tsuji, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603384200 · Cited by 156
Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
Melisi, D., Xia, Q., Paradiso, G., Ling, J., Moccia, T., Carbone, C., Budillon, A., Abbruzzese, J. L., & Chiao, P. J. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr243 · Cited by 156
LMP1 TRAFficking Activates Growth and Survival pathways
Soni, V., Cahir-McFarland, E. D., & Kieff, E. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_14 · Cited by 153
Protein Phosphatase 6 Down-regulates TAK1 Kinase Activation in the IL-1 Signaling Pathway
Kajino, T., Ren, H., Iemura, S., Natsume, T., Stefansson, B., Brautigan, D. L., Matsumoto, K., & Ninomiya‐Tsuji, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608155200 · Cited by 138
Sato, Y., Yoshikawa, A., Yamashita, M., Yamagata, A., & Fukai, S. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.345 · Cited by 138
Two Mechanistically and Temporally Distinct NF-κB Activation Pathways in IL-1 Signaling
Yamazaki, K., Gohda, J., Kanayama, A., Miyamoto, Y., Sakurai, H., Yamamoto, M., Akira, S., Hayashi, H., Su, B., & Inoue, J. (2009) · Science Signaling · doi:10.1126/scisignal.2000387 · Cited by 133
Self-citationTAB2 Is Essential for Prevention of Apoptosis in Fetal Liver but Not for Interleukin-1 Signaling
Sanjo, H., Takeda, K., Tsujimura, T., Ninomiya‐Tsuji, J., Matsumoto, K., & Akira, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1231-1238.2003 · Cited by 128
Sato, S., Sanjo, H., Tsujimura, T., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Takeuchi, O., & Akira, S. (2006) · International Immunology · doi:10.1093/intimm/dxl082 · Cited by 123
TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney
Ma, F. Y., Tesch, G. H., Ozols, E., Xie, M., Schneider, M. D., & Nikolic‐Paterson, D. J. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00018.2011 · Cited by 114
Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S. M., Pass, A. K., Nuchtern, J. G., Zhang, D., Fu, S., Schneider, M. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802825200 · Cited by 112
Shinohara, H., Maeda, S., Watarai, H., & Kurosaki, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070379 · Cited by 111
Sakurai, H., Shigemori, N., Hasegawa, K., & Sugita, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8124 · Cited by 101
Self-citationStructural Basis for the Interaction of TAK1 Kinase with its Activating Protein TAB1
Brown, K., Vial, S., Dedi, N., Long, J. M., Dunster, N. J., & Cheetham, G. M. T. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.098 · Cited by 98
Komatsu, Y., Shibuyà, H., Takeda, N., Ninomiya‐Tsuji, J., Yasui, T., Miyado, K., Sekimoto, T., Ueno, N., Matsumoto, K., & Yamada, G. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00391-x · Cited by 96
Protein Kinases as Small Molecule Inhibitor Targets in Inflammation
Gaestel, M., Mengel, A., Bothe, U., & Asadullah, K. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781696636 · Cited by 96
TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis
Safina, A. F., Ren, M.-Q., Vandette, E., & Bakin, A. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210768 · Cited by 94
Tokunaga, F., & Iwaï, K. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.01.011 · Cited by 93
Strippoli, R., Benedicto, I., Foronda, M., Lozano, M. L. P., Sánchez-Perales, S., López‐Cabrera, M., & del Pozo, M. Á. (2010) · Journal of Cell Science · doi:10.1242/jcs.071647 · Cited by 92
Kim, S. I., Kwak, J. H., Na, H.-J., Kim, J. K., Ding, Y., & Choi, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007146 · Cited by 87
Nishimura, M., Shin, M.-S., Singhirunnusorn, P., Suzuki, S., Kawanishi, M., Koizumi, K., Saiki, I., & Sakurai, H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00375-09 · Cited by 85
Self-citationZhao, Y., Thornton, A. M., Kinney, M. C., Ma, C. A., Spinner, J. J., Fuss, I. J., Shevach, E. M., & Jain, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.292961 · Cited by 83
Neil, J. R., & Schiemann, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3094 · Cited by 83
Sakurai, H., Nishi, A., Sato, N., Mizukami, J., Miyoshi, H., & Sugita, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02379-3 · Cited by 81
Self-citationA critical role of TAK1 in B-cell receptor–mediated nuclear factor κB activation
Schuman, J., Chen, Y., Podd, A., Yu, M., Liu, H.-H., Wen, R., Chen, Z. J., & Wang, D. (2009) · Blood · doi:10.1182/blood-2008-08-176057 · Cited by 80
Wu, X., & Sun, S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400931 · Cited by 79
Mao, R., Fan, Y., Mou, Y., Zhang, H., Fu, S., & Yang, J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.09.006 · Cited by 73
TRAF6 inhibits Th17 differentiation and TGF-β–mediated suppression of IL-2
Cejas, P. J., Walsh, M. C., Pearce, E. L., Han, D., Pritchard, G. H., Artis, D., Turka, L. A., & Choi, Y. (2010) · Blood · doi:10.1182/blood-2009-09-242768 · Cited by 70
Postler, T. S., & Desrosiers, R. C. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2011.12.005 · Cited by 65
Courties, G., Seiffart, V., Présumey, J., Escriou, V., Scherman, D., Zwerina, J., Ruiz, G., Ziętara, N., Jabłońska, J., Weiß, S., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269605 · Cited by 63
Kajino‐Sakamoto, R., Omori, E., Nighot, P. K., Blikslager, A. T., Matsumoto, K., & Ninomiya‐Tsuji, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903587 · Cited by 60
Wang, Y., Huang, G., Vogel, P., Neale, G. A. M., Reizis, B., & Chi, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115635109 · Cited by 57
Thiefes, A., Wolf, A., Doerrie, A., Graßl, G. A., Matsumoto, K., Autenrieth, I. B., Bohn, E., Sakurai, H., Niedenthal, R. K., Resch, K., et al. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400754 · Cited by 55
Self-citationTAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP
Morioka, S., Omori, E., Kajino, T., Kajino‐Sakamoto, R., Matsumoto, K., & Ninomiya‐Tsuji, J. (2009) · Oncogene · doi:10.1038/onc.2009.110 · Cited by 50
Choo, M., Kawasaki, N., Singhirunnusorn, P., Koizumi, K., Sato, S., Akira, S., Saiki, I., & Sakurai, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0379 · Cited by 47
Self-citationChoo, M., Sakurai, H., Koizumi, K., & Saiki, I. (2005) · International Journal of Cancer · doi:10.1002/ijc.21734 · Cited by 44
Self-citationTAK1–TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells
Safina, A. F., Sotomayor, P. C., Limoge, M., Morrison, C., & Bakin, A. V. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0196 · Cited by 38
Suzuki, S., Zhou, Y., Refaat, A., Takasaki, I., Koizumi, K., Yamaoka, S., Tabuchi, Y., Saiki, I., & Sakurai, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031476 · Cited by 37
Self-citationMartin, S. E., Wu, Z., Gehlhaus, K., Jones, T. L., Zhang, Y., Guha, R., Miyamoto, S., Pommier, Y. G., & Caplen, N. J. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911797264734 · Cited by 36
Rajasekaran, K., Chu, H., Kumar, P., Xiao, Y., Tinguely, M., Samarakoon, A., Kim, T. W., Li, X., Thakar, M. S., Zhang, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261917 · Cited by 31
Fan, Y., Shi, Y., Liu, S., Mao, R., An, L., Zhao, Y., Zhang, H., Zhang, F., Xu, G., Qin, J., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.017 · Cited by 31
Suzuki, S., Singhirunnusorn, P., Mori, A., Yamaoka, S., Kitajima, I., Saiki, I., & Sakurai, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700065200 · Cited by 30
Self-citation
Cited by
Mitogen-activated protein kinases in innate immunity
Arthur, J. S. C., & Ley, S. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3495 · Cited by 1,855
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785
“H. Sakurai, Targeting of TAK1 in inflammatory disorders and cancer.”
BackgroundInfluentialTNF and MAP kinase signalling pathways
Sabio, G., & Davis, R. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.009 · Cited by 700
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Reactive oxygen species (ROS) in macrophage activation and function in diabetes
Rendra, E., Riabov, V., Mossel, D. M., Sevastyanova, T., Harmsen, M. C., & Kzhyshkowska, J. (2019) · Immunobiology · doi:10.1016/j.imbio.2018.11.010 · Cited by 636
Metadata
- Authors
- Sakurai, H.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 33
- Issue
- 10
- Pages
- 522-530
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2059421466
- Cited by
- 373
- References
- 88
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.